Figure 3.

Increase in neutralising antibody activity during vaccination schedule with mRNA-1273.

Matched values of neutralising antibody activity elicited by vaccination with mRNA-1273 at time of second vaccine shot (T1a) and 28 days since completion of vaccination schedule (T1b) in people living with HIV (A) and HDs (B). Before-after graph with matched individuals, each point represents a single participant. Statistics calculated using Wilcoxon match signed-rank test.

PLWHIV=people living with HIV; HDs=healthy donors.